ACUTE LYMPHOBKASTIC LEUKEMIA
Clinical trials for ACUTE LYMPHOBKASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE LYMPHOBKASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE LYMPHOBKASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients who have run out of options
Disease control Not yet recruitingThis early-stage study tests an experimental drug called STR-P004 in 11 adults with relapsed or treatment-resistant CD19-positive acute lymphoblastic leukemia. The main goals are to check safety and find the right dose, while also looking for signs that the drug can fight the can…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: NA • Sponsor: Starna Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:49 UTC
-
Engineered immune cells take on tough blood cancers
Disease control Not yet recruitingThis study tests a new treatment using a patient's own immune cells, modified to target and kill cancer cells in adults with leukemia or lymphoma that has come back or not responded to standard therapy. The trial has two phases: first to check safety, then to see how well the tre…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat blood cancers
Disease control Not yet recruitingThis study tests a new treatment called SHB-02-CD19 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified to recognize and attack cancer cells. The goal is …
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Sheba Medical Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New 'Sandwich' therapy aims to stop leukemia relapse after transplant
Disease control Not yet recruitingThis study tests a new treatment plan for young adults and adults with B-cell acute lymphoblastic leukemia (B-ALL). The approach uses immunotherapy before an autologous stem cell transplant, followed by a 'sandwich' of two types of CAR-T cells (CD22 and CD19) to try to prevent th…
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 04, 2026 16:19 UTC
-
Real-World data sought on leukemia drug ponatinib
Knowledge-focused Not yet recruitingThis study reviews medical records of about 103 adults with Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) who received the drug ponatinib as their first treatment in regular medical practice. Researchers want to see how many patients achieve a deep level of cancer …
Matched conditions: ACUTE LYMPHOBKASTIC LEUKEMIA
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Knowledge-focused
Last updated May 11, 2026 20:50 UTC